Induction of Strain-Transcending Immunity against Plasmodium chabaudi adami Malaria with a Multiepitope DNA Vaccine

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Infection and Immunity

• Publication date

  2005-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1128/IAI.73.5.2974-2985.2005PMID 15845504PMCID PMC1087359
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Oral Immunization with a Combination of Plasmodium yoelii Merozoite Surface Proteins 1 and 4/5 Enhances Protection against Lethal Malaria Challenge

  2004cited by this paper
• Merozoite Surface Protein 4/5 Provides Protection against Lethal Challenge with a Heterologous Malaria Parasite Strain

  2004cited by this paper
• Novel Antigen Identification Method for Discovery of Protective Malaria Antigens by Rapid Testing of DNA Vaccines Encoding Exons from the Parasite Genome

  2004cited by this paper
• The purine salvage enzyme hypoxanthine guanine xanthine phosphoribosyl transferase is a major target antigen for cell-mediated immunity to malaria

  2003cited by this paper
• Expression profiling of the schizont and trophozoite stages of Plasmodium falciparum with a long-oligonucleotide microarray

  2003cited by this paper
• Immunization against Plasmodium chabaudi malaria using combined formulations of apical membrane antigen-1 and merozoite surface protein-1.

  2003cited by this paper
• Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans

  2003cited by this paper
• Discovery of Gene Function by Expression Profiling of the Malaria Parasite Life Cycle

  2003cited by this paper
• A Plasmodium falciparum candidate vaccine based on a six-antigen polyprotein encoded by recombinant poxviruses

  2003cited by this paper
• Induction of Specific T-Cell Responses, Opsonizing Antibodies, and Protection against Plasmodium chabaudi adami Infection in Mice Vaccinated with Genomic Expression Libraries Expressed in Targeted and Secretory DNA Vectors

  2003cited by this paper
• Geographical Structure of Diversity and Differences between Symptomatic and Asymptomatic Infections for Plasmodium falciparum Vaccine Candidate AMA1

  2003cited by this paper
• MHC-guided processing: binding of large antigen fragments

  2003cited by this paper
• Progress in the development of recombinant and synthetic blood-stage malaria vaccines

  2003influential reference
• Utilization of genomic sequence information to develop malaria vaccines

  2003influential reference
• MHC-guided processing: binding of large antigen fragments

  2003cited by this paper
• Immunogenetics and the design of Plasmodium falciparum vaccines for use in malaria-endemic populations.

  2002cited by this paper
• High-Level Expression of the Malaria Blood-Stage Vaccine Candidate Plasmodium falciparum Apical Membrane Antigen 1 and Induction of Antibodies That Inhibit Erythrocyte Invasion

  2002cited by this paper
• Vaccination of Monkeys with Recombinant Plasmodium falciparum Apical Membrane Antigen 1 Confers Protection against Blood-Stage Malaria

  2002cited by this paper
• The role of antibodies to Plasmodium falciparum-infected-erythrocyte surface antigens in naturally acquired immunity to malaria.

  2002cited by this paper
• Sequence of Plasmodium falciparum chromosomes 1, 3–9 and 13

  2002cited by this paper
• Immunity to asexual blood stage malaria and vaccine approaches

  2002cited by this paper
• Sequence of Plasmodium falciparum chromosomes 2, 10, 11 and 14

  2002cited by this paper
• Genome sequence of the human malaria parasite Plasmodium falciparum

  2002cited by this paper
• Protection of Rhesus Macaques against Lethal Plasmodium knowlesi Malaria by a Heterologous DNA Priming and Poxvirus Boosting Immunization Regimen

  2002cited by this paper
• Progress and challenges for malaria vaccines

  2002cited by this paper
• Immunization with a Combination of Merozoite Surface Proteins 4/5 and 1 Enhances Protection against Lethal Challenge with Plasmodium yoelii

  2002cited by this paper
• A recombinant blood-stage malaria vaccine reduces Plasmodium falciparum density and exerts selective pressure on parasite populations in a phase 1-2b trial in Papua New Guinea.

  2002cited by this paper
• Mouse models of blood-stage malaria infections: immune responses and cytokines involved in protection and pathology.

  2002cited by this paper
• In Vitro Studies with Recombinant Plasmodium falciparum Apical Membrane Antigen 1 (AMA1): Production and Activity of an AMA1 Vaccine and Generation of a Multiallelic Response

  2002cited by this paper
• Vaccines against asexual stage malaria parasites.

  2002cited by this paper
• Sequence of Plasmodium falciparum chromosome 12

  2002cited by this paper
• DNA Immunization by Plasmodium falciparum Liver-Stage Antigen 3 Induces Protection againstPlasmodium yoelii Sporozoite Challenge

  2001cited by this paper
• A Critical Role of Fc Receptor-Mediated Antibody-Dependent Phagocytosis in the Host Resistance to Blood-Stage Plasmodium berghei XAT Infection1

  2001cited by this paper
• Human Antibodies against Plasmodium falciparumLiver-Stage Antigen 3 Cross-React with Plasmodium yoelii Preerythrocytic-Stage Epitopes and Inhibit Sporozoite Invasion In Vitro and In Vivo

  2001cited by this paper
• Antibody Recognition of Rodent Malaria Parasite Antigens Exposed at the Infected Erythrocyte Surface: Specificity of Immunity Generated in Hyperimmune Mice

  2001cited by this paper
• Fcgamma receptor IIa (CD32) polymorphism is associated with protection of infants against high-density Plasmodium falciparum infection. VII. Asembo Bay Cohort Project.

  2001cited by this paper
• Expression library immunization protects mice against a challenge with virulent rodent malaria.

  2000cited by this paper
• Central Role of Endogenous Gamma Interferon in Protective Immunity against Blood-Stage Plasmodium chabaudi AS Infection

  2000cited by this paper
• Antibodies against Ribosomal Phosphoprotein P0 ofPlasmodium falciparum Protect Mice against Challenge with Plasmodium yoelii

  2000cited by this paper
• Immunoglobulin G3 Antibodies Specific for the 19-Kilodalton Carboxyl-Terminal Fragment of Plasmodium yoelii Merozoite Surface Protein 1 Transfer Protection to Mice Deficient in Fc-γRI Receptors

  2000cited by this paper
• Malaria blood-stage infection and its control by the immune system.

  2000cited by this paper
• Identification of Vaccine Candidates for Experimental Visceral Leishmaniasis by Immunization with Sequential Fractions of a cDNA Expression Library

  2000cited by this paper
• Differential effect and interaction of monocytes, hyperimmune sera, and immunoglobulin G on the growth of asexual stage Plasmodium falciparum parasites.

  1999cited by this paper
• The complete nucleotide sequence of chromosome 3 of Plasmodium falciparum

  1999cited by this paper
• Protective immune responses induced by vaccination with an expression genomic library of Leishmania major.

  1999cited by this paper
• Plasmodium: immunization with carboxyl-terminal regions of MSP-1 protects against homologous but not heterologous blood-stage parasite challenge.

  1999cited by this paper
• A role for cytokines in potentiation of malaria vaccines through immunological modulation of blood stage infection

  1999cited by this paper
• Mice immunised with synthetic peptide from N-terminal conserved region of merozoite surface antigen-2 of human malaria parasite Plasmodium falciparum can control infection induced by Plasmodium yoelii yoelii 265BY strain.

  1999cited by this paper
• Fc receptors are not required for antibody-mediated protection against lethal malaria challenge in a mouse model.

  1998cited by this paper
• Immunisation with recombinant AMA-1 protects mice against infection with Plasmodium chabaudi.

  1998cited by this paper
• Protection by minigenes: a novel approach of DNA vaccines.

  1998cited by this paper
• Vaccines against the blood stages of falciparum malaria.

  1998cited by this paper
• Variant- and strain-specific immunity in Saimiri infected with Plasmodium falciparum.

  1998cited by this paper
• Acute Plasmodium chabaudi chabaudi Malaria Infection Induces Antibodies Which Bind to the Surfaces of Parasitized Erythrocytes and Promote Their Phagocytosis by Macrophages In Vitro

  1998cited by this paper
• Fc receptors.

  1997cited by this paper
• Immunization with a recombinant C-terminal fragment of Plasmodium yoelii merozoite surface protein 1 protects mice against homologous but not heterologous P. yoelii sporozoite challenge

  1997cited by this paper
• Circumventing genetic restriction of protection against malaria with multigene DNA immunization: CD8+ cell-, interferon gamma-, and nitric oxide-dependent immunity

  1996cited by this paper
• The Disulfide Bond Structure of Plasmodium Apical Membrane Antigen-1*

  1996cited by this paper
• Induction of cytotoxic T lymphocytes and antitumor immunity with DNA vaccines expressing single T cell epitopes.

  1996cited by this paper
• Protective immune responses to apical membrane antigen 1 of Plasmodium chabaudi involve recognition of strain-specific epitopes

  1996cited by this paper
• Mechanisms underlying the monocyte-mediated antibody-dependent killing of Plasmodium falciparum asexual blood stages

  1995cited by this paper
• Protection against mycoplasma infection using expression-library immunization

  1995cited by this paper
• Immunity to erythrocytic stages of malarial parasites.

  1994cited by this paper
• Mice immunized with a synthetic peptide construct corresponding to an epitope present on a Plasmodium falciparum antigen are protected against Plasmodium chabaudi challenge

  1993cited by this paper
• Synthetic peptides based on conserved Plasmodium falciparum antigens are immunogenic and protective against Plasmodium yoelii malaria

  1993cited by this paper
• Protective immunization with invariant peptides of the Plasmodium falciparum antigen MSA2.

  1992cited by this paper
• Mechanisms of protective immunity against asexual blood stages of Plasmodium falciparum in the experimental host Saimiri.

  1992cited by this paper
• Naturally acquired immunity to Plasmodium falciparum

  1991cited by this paper
• Fc receptors.

  1991cited by this paper
• Naturally acquired immunity to Plasmodium falciparum.

  1991cited by this paper
• Opsonization as an effector mechanism in human protection against asexual blood stages of Plasmodium falciparum: functional role of IgG subclasses.

  1990cited by this paper
• Demonstration of the role of cytophilic antibody in resistance to malaria parasites (Plasmodium berghei) in rats

  1978cited by this paper
• Epidemiological significance of repeated infections with homologous and heterologous strains and species of Plasmodium.

  1966cited by this paper

• DNA-Based Vaccines: Advances, Applications, and Future Prospects

  2026cites this paper
• Safety, immunogenicity, and cross-species protection of a plasmid DNA encoding Plasmodium falciparum SERA5 polypeptide, microbial epitopes and chemokine genes in mice and olive baboons

  2017cites this paper
• RETRACTED ARTICLE: Recent developments in DNA vaccination approaches against poultry coccidiosis and its future endeavours

  2014cites this paper
• A study of recombinant Plasmodium falciparum PFC0760c.

  2013cites this paper
• Drugs for Parasitic Infections: Advances in the Discovery of New Antimalarials

  2013cites this paper
• Macrophage Migration Inhibitory Factor: A Downregulator of Early T Cell-Dependent IFN-γ Responses in Plasmodium chabaudi adami (556 KA)-Infected Mice

  2011cites this paper
• Synthetic Plasmodium-Like Hemozoin Activates the Immune Response: A Morphology - Function Study

  2009cites this paper
• Induced immune response of DNA vaccine encoding an association MSP1a, MSP1b, and MSP5 antigens of Anaplasma marginale.

  2008cites this paper
• Rapid production of a plasmid DNA encoding a malaria vaccine candidate via amino-functionalized poly(GMA-co-EDMA) monolith

  2008cites this paper
• Natural regulatory (CD4+CD25+FOXP+) T cells control the production of pro-inflammatory cytokines during Plasmodium chabaudi adami infection and do not contribute to immune evasion.

  2008cites this paper
• Potent antimalarial and transmission-blocking activities of centanamycin, a novel DNA-binding agent.

  2008cites this paper
• A Genetic Analysis of Two Strains of Plasmodium chabaudi adami that Differ in Growth and Pathogenicity

  2008cites this paper
• Vaccination with a Plasmodium chabaudi adami multivalent DNA vaccine cross-protects A/J mice against challenge with P. c. adami DK and virulent Plasmodium chabaudi chabaudi AS parasites.

  2008cites this paper
• DNA vaccination against the parasite enzyme gamma-glutamylcysteine synthetase confers protection against Leishmania donovani infection.

  2007cites this paper
• Identification by genomic immunization of a pool of DNA vaccine candidates that confer protective immunity in mice against Neisseria meningitidis serogroup B.

  2007cites this paper
• Parasite vaccines: the new generation.

  2007cites this paper
• Advances in the Discovery of New Antimalarials

  2007cites this paper
• Zoonotic risks of rodent in livestock production : zoönotische risico's van knaagdieren in de veehouderij

  2006cites this paper
• [Zoonotic risk of rodents in livestock production].

  2006cites this paper
• The A/T-specific DNA alkylating agent adozelesin inhibits Plasmodium falciparum growth in vitro and protects mice against Plasmodium chabaudi adami infection.

  2006cites this paper
• High road, low road? Choices and challenges on the pathway to a malaria vaccine

  2006cites this paper